“There is always the risk that interim analyses might occur after the Sufficient Information Threshold has been reached. Bayesian methods alleviate some of this risk.”
Cytel is a Massachusetts-based firm that designs software products offering solutions such as clinical trial design and data analysis for biotech and pharmaceutical sectors.